Production (Stage)
Theratechnologies Inc.
TH.TO
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -552.08% | 102.61% | -186.86% | 514.34% | 109.86% |
| Total Depreciation and Amortization | -62.52% | -5.03% | -14.41% | -43.66% | 35.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 529.43% | 121.44% | 217.78% | 134.48% | -58.11% |
| Change in Net Operating Assets | 584.58% | -958.62% | 25.48% | -91.76% | -162.59% |
| Cash from Operations | 4,376.90% | -470.49% | 94.47% | -13.60% | 91.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -5,248.51% | 16.90% | 35.95% | -116.81% |
| Cash from Investing | 94.16% | -5,250.75% | 16.90% | 39.61% | -118.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5,543.44% | -56.56% | -53,131.93% | 93.46% | -27.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 5.88% | 81.57% | 81.43% | -254.11% |
| Cash from Financing | -977.46% | 1,796.36% | -181.00% | 76.40% | -164.05% |
| Foreign Exchange rate Adjustments | 650.00% | -62.50% | -1,350.00% | -75.00% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 617.13% | -545.88% | -198.22% | 277.00% | 64.97% |